Achieves Most Profitable Quarter in Company’s HistoryRevenue Up 33% Year-over-year to $354 MillionBELLINGHAM, Wash., Aug. 05, 2020 (GLOBE NEWSWIRE) — […]
HOUSTON, Aug. 05, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by dysregulated […]
12-month, double-blind, placebo-controlled, multi-national study enrolled 176 participantsTopline results expected in fourth quarter of 2021Dermatomyositis is a rare, systemic autoimmune […]